Primary glomerulonephritis is one of the most common kidney diseases, and a main cause of end-stage renal disease (ESRD). Glomerulonephritis has multiple subtypes, each with different physiopathologies, clinical presentation, and management requirements, which makes treatment difficult. As a complex set of diseases, the choice of symptomatic and specific treatment is critical to ameliorating the relentless course of glomerulonephritis. Focusing on all subtypes of primary glomerulonephritis, from epidemiology and classification, to pathogenesis and treatment, this volume includes the latest research and evidence-based practice. With a strong emphasis on drugs used for both symptomatic and specific treatments, the mechanisms of action, effectiveness, and potential toxicity are considered for therapeutic strategies in the different subtypes of primary glomerulonephritis. Each chapter follows a clear and logical format that allows easy access to key information, and provides extensive references for further information.